Griseofulvin solvate solid dispersions with synergistic effect against fungal biofilms.

[1]  L. S. Taylor,et al.  Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements. , 2018, Molecular pharmaceutics.

[2]  Han Liu,et al.  Block Copolymer Nanoparticles Remove Biofilms of Drug-Resistant Gram-Positive Bacteria by Nanoscale Bacterial Debridement. , 2018, Nano letters.

[3]  G. Simonetti,et al.  In vitro biofilms and antifungal susceptibility of dermatophyte and non‐dermatophyte moulds involved in foot mycosis , 2018, Mycoses.

[4]  L. S. Taylor,et al.  Rifampin Stability and Solution Concentration Enhancement Through Amorphous Solid Dispersion in Cellulose ω-Carboxyalkanoate Matrices. , 2018, Journal of pharmaceutical sciences.

[5]  Dinesh Kumar,et al.  Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals☆ , 2017, Advanced drug delivery reviews.

[6]  R. Brilhante,et al.  Quantitative and structural analyses of the in vitro and ex vivo biofilm‐forming ability of dermatophytes , 2017, Journal of medical microbiology.

[7]  Gagandeep Singh,et al.  Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines , 2017, Journal of fungi.

[8]  R. D. dos Santos,et al.  Effectiveness of five antidandruff cosmetic formulations against planktonic cells and biofilms of dermatophytes , 2015, Saudi journal of biological sciences.

[9]  A. Nangia,et al.  Pharmaceutical cocrystals: walking the talk. , 2016, Chemical communications.

[10]  M. Kataoka,et al.  Characterizing the dissolution profiles of supersaturable salts, cocrystals, and solvates to enhance in vivo oral absorption. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  A. Sahoo,et al.  Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review , 2016, Indian dermatology online journal.

[12]  Kaitlin F. Mitchell,et al.  The Extracellular Matrix of Fungal Biofilms. , 2016, Advances in experimental medicine and biology.

[13]  A. H. Al-Hamadani,et al.  In vitro, determination of optimal conditions of growth and proteolytic activity of clinical isolates of Trichophyton rubrum , 2015 .

[14]  A. Oliver,et al.  ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  A. Fusco-Almeida,et al.  In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms , 2014, Biofouling.

[16]  R. Tan,et al.  Solvates of the antifungal drug griseofulvin: structural, thermochemical and conformational analysis. , 2014, Acta crystallographica Section B, Structural science, crystal engineering and materials.

[17]  Mohammad Wahid Ansari,et al.  The legal status of in vitro embryos , 2014 .

[18]  M. Eddleston,et al.  On the polymorphism of griseofulvin: identification of two additional polymorphs. , 2013, Journal of pharmaceutical sciences.

[19]  F. Ito.  Matrix-isolation infrared studies of 1:1 molecular complexes containing chloroform (CHCl3) and Lewis bases: seamless transition from blue-shifted to red-shifted hydrogen bonds. , 2012, The Journal of chemical physics.

[20]  D. Rani,et al.  In Vitro Antibacterial and Antifungal Properties of Aqueous and Non-Aqueous Frond Extracts of Psilotum nudum, Nephrolepis biserrata and Nephrolepis cordifolia , 2010, Indian journal of pharmaceutical sciences.

[21]  Aditya K. Gupta,et al.  In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients. , 2009, Medical mycology.

[22]  S. Stegemann,et al.  When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  D. A. Santos,et al.  In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole , 2007, Mycoses.

[24]  F. Wignall,et al.  Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole , 2004, The British journal of dermatology.

[25]  N. Taylor,et al.  Stable solvates in solution of lithium bis(trifluoromethylsulfone)imide in glymes and other aprotic solvents: Phase diagrams, crystallography and Raman spectroscopy , 2002 .

[26]  R. Donlan,et al.  Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.

[27]  S. Hoag,et al.  Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. , 2001, International journal of pharmaceutics.

[28]  E. Suzuki,et al.  Thermal Analysis of Griseofulvin-Chloroform System by High Pressure Differential Scanning Calorimetry , 1983 .

[29]  P. Prasad,et al.  Laser Raman investigation of pharmaceutical solids: griseofulvin and its solvates. , 1981, Journal of pharmaceutical sciences.

[30]  E. Shefter,et al.  Crystal structure analysis of the desolvation of the chloroform solvate of griseofulvin , 1979 .

[31]  A. Lesikar.  Effect of association complexes on the glass transition in organic halide mixtures , 1976 .

[32]  E. Wenkert,et al.  Carbon-13 nuclear magnetic resonance spectroscopy of naturally occurring substances. XXX. Griseofulvin , 1975 .